Tomomi Niino

Primary Clinical Development Dept.
Chugai Pharmaceutical Co., Ltd.

Presentation(s):

• VPB0206 - Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM